Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 81,787	$ 78,708
Research and development incentive receivable	747	917
Prepaid expenses and other current assets	5,344	3,682
Total current assets	87,878	83,307
Property and equipment, net	1,514	1,237
Goodwill	17,351	27,109
Right-of-use assets	8,710	7,960
Other assets	1,723	3,258
Assets, Total	117,176	122,871
Current liabilities:
Accounts payable	4,283	3,144
Accrued expenses	7,870	8,018
Current portion of lease liability	1,075	786
Long-term Debt, Current Maturities	795	0
Liabilities, Current, Total	14,023	11,948
Long-term debt, including accretion, net of discount	33,139	33,178
Lease liabilities	4,776	4,484
Other liabilities	826	462
Total liabilities	52,764	50,072
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common Stock	28	16
Additional paid-in capital	347,374	267,077
Accumulated other comprehensive loss	(119)	(119)
Accumulated deficit	(282,871)	(194,175)
Total stockholders’ equity	64,412	72,799
Total liabilities and stockholders’ equity	$ 117,176	$ 122,871
Common stock, issued (in shares)	28,127,657	16,305,731
Common stock, outstanding (in shares)	28,127,657	16,305,731
Common stock, authorized (in shares)	125,000,000	125,000,000